Bollard Group’s AstraZeneca AZN Stock Holding History

Bollard Group’s Portfolio AZN Stock Details AZN Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$110K	Buy	1,580 +49	+3%	+$3.41K	﹤0.01%	194
2025 Q1	$113K	Buy	1,531 +21	+1%	+$1.55K	﹤0.01%	180
2024 Q4	$99K	Hold	1,510	–	–	﹤0.01%	186
2024 Q3	$118K	Buy	1,510 +9	+0.6%	+$703	﹤0.01%	192
2024 Q2	$117K	Hold	1,501	–	–	﹤0.01%	190
2024 Q1	$102K	Buy	1,501 +22	+1%	+$1.5K	﹤0.01%	191
2023 Q4	$100K	Hold	1,479	–	–	﹤0.01%	187
2023 Q3	$100K	Buy	1,479 +10	+0.7%	+$676	﹤0.01%	183
2023 Q2	$105K	Buy	1,469 +528	+56%	+$37.7K	﹤0.01%	188
2023 Q1	$65K	Buy	941 +13	+1%	+$898	﹤0.01%	208
2022 Q4	$63K	Hold	928	–	–	﹤0.01%	202
2022 Q3	$51K	Buy	928 +7	+0.8%	+$385	﹤0.01%	213
2022 Q2	$61K	Hold	921	–	–	﹤0.01%	221
2022 Q1	$61K	Buy	921 +14	+2%	+$927	﹤0.01%	323
2021 Q4	$53K	Hold	907	–	–	﹤0.01%	341
2021 Q3	$54K	Buy	+907	New	+$54K	﹤0.01%	338
2019 Q3	–	Sell	-47,188	Closed	-$1.95M	–	234
2019 Q2	$1.95M	Hold	47,188	–	–	0.07%	114
2019 Q1	$1.91M	Buy	47,188 +1,006	+2%	+$40.7K	0.07%	112
2018 Q4	$1.75M	Hold	46,182	–	–	0.08%	111
2018 Q3	$1.83M	Buy	46,182 +529	+1%	+$20.9K	0.07%	110
2018 Q2	$1.6M	Hold	45,653	–	–	0.07%	113
2018 Q1	$1.6M	Buy	45,653 +1,187	+3%	+$41.5K	0.08%	115
2017 Q4	$1.54M	Hold	44,466	–	–	0.07%	112
2017 Q3	$1.51M	Buy	44,466 +588	+1%	+$19.9K	0.08%	119
2017 Q2	$1.5M	Hold	43,878	–	–	0.08%	123
2017 Q1	$1.37M	Buy	43,878 +1,287	+3%	+$40.1K	0.08%	123
2016 Q4	$1.16M	Hold	42,591	–	–	0.08%	129
2016 Q3	$1.4M	Buy	42,591 +568	+1%	+$18.7K	0.09%	116
2016 Q2	$1.27M	Buy	42,023 +2,050	+5%	+$61.9K	0.09%	116
2016 Q1	$1.13M	Buy	39,973 +1,269	+3%	+$35.7K	0.09%	118
2015 Q4	$1.31M	Hold	38,704	–	–	0.11%	108
2015 Q3	$1.23M	Buy	38,704 +22,679	+142%	+$722K	0.1%	121
2015 Q2	$1.02M	Hold	16,025	–	–	0.08%	138
2015 Q1	$1.1M	Buy	16,025 +9,225	+136%	+$632K	0.08%	131
2014 Q4	$479K	Buy	+6,800	New	+$479K	0.04%	154